Neuroblastoma Australia funded the pre-clinical research for CBL137 in combination with other targeted therapies at the Children’s Cancer Institute, Randwick through groups led by Professors Michelle Haber, Murray Norris and Glenn Marshall.
Neuroblastoma Australia has raised over $4 million for innovative research, funding 17 early stage projectsfocused on changing the future for children with neuroblastoma – one of the most aggressive childhood cancers. Behind every dollar raised are children and families facing the devastating impact of this disease, like the story shared here.
Donate now to help fund potentially life-changing medical research that gives hope to children diagnosed with neuroblastoma. Donations are secure and you’ll receive an immediate tax-deductible receipt. Thank you.
